
Custom Lucite marking a global joint venture between Janssen Biotech and TESARO. The partnership is focused on the treatment of prostate cancer. (6ALR124)

Custom Lucite marking a global joint venture between Janssen Biotech and TESARO. The partnership is focused on the treatment of prostate cancer. (6ALR124)
"*" indicates required fields